tiprankstipranks
Trending News
More News >
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
US Market

Burning Rock Biotech (BNR) Financial Statements

Compare
90 Followers

Burning Rock Biotech Financial Overview

Burning Rock Biotech's market cap is currently $425.60M. The company's EPS TTM is $-0.217; its P/E ratio is -20.90; Burning Rock Biotech is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 515.82M¥ 537.43M¥ 563.24M¥ 507.86M¥ 429.90M
Gross Profit¥ 362.40M¥ 363.23M¥ 380.04M¥ 364.15M¥ 313.92M
Operating Income¥ -357.56M¥ -669.32M¥ -980.41M¥ -797.06M¥ -412.40M
EBITDA¥ -270.23M¥ -517.90M¥ -856.31M¥ -746.50M¥ -373.26M
Net Income¥ -346.63M¥ -653.69M¥ -971.23M¥ -796.70M¥ -407.24M
Balance Sheet
Cash & Short-Term Investments¥ 519.85M¥ 615.10M¥ 905.45M¥ 1.50B¥ 2.26B
Total Assets¥ 885.30M¥ 1.04B¥ 1.59B¥ 2.28B¥ 2.66B
Total Debt¥ 52.32M¥ 12.32M¥ 50.79M¥ 86.69M¥ 46.88M
Net Debt¥ -467.53M¥ -602.77M¥ -854.66M¥ -1.34B¥ -1.85B
Total Liabilities¥ 304.48M¥ 271.59M¥ 429.13M¥ 433.28M¥ 242.02M
Stockholders' Equity¥ 580.83M¥ 768.41M¥ 1.16B¥ 1.85B¥ 2.42B
Cash Flow
Free Cash Flow¥ -98.24M¥ -265.17M¥ -518.84M¥ -691.33M¥ -153.08M
Operating Cash Flow¥ -92.26M¥ -255.78M¥ -456.81M¥ -477.89M¥ -73.54M
Investing Cash Flow¥ -4.41M¥ -9.30M¥ -7.46M¥ 81.70M¥ -109.31M
Financing Cash Flow¥ -72.00K¥ -48.83M¥ -86.24M¥ -52.90M¥ 2.17B
Currency in CNY

Burning Rock Biotech Earnings and Revenue History

Burning Rock Biotech Debt to Assets

Burning Rock Biotech Cash Flow

Burning Rock Biotech Forecast EPS vs Actual EPS